Skip to main content
. 2020 Oct 13;16(10):e1008267. doi: 10.1371/journal.pcbi.1008267

Fig 9. Toxic proteopathy progression dynamics in the primary tauopathy patient.

Fig 9

Toxic Aβ (top row) and opacity exaggerated toxic Aβ progression (second row); Toxic τP (third row) and opacity exaggerated toxic τP progression (last row). Color scale is identical to Fig 1. (See also: supplementary S5 Video, supplementary S6 Video and supplementary S2 Data).